ADAPT-DES Trial: 1 in 8 patients with PCI-DES have increased mortality supriya kashyap kashyap30 Oct 2016 9:08 AM IST1 in 8 patients undergoing successful PCI with DES implantation experience clinically relevant bleeding, MI, or stent thrombosis during the ensuing 2...
First in human of new polymer-free stent demonstrates favorable angiographic, imaging-based outcomes at nine-months supriya kashyap kashyap3 Nov 2016 12:50 PM ISTA first-in-human study of a new polymer-free drug-filled stent, which provides controlled drug elution from an internal lumen, indicated non-inferior...
Optimal duration of DAPT after PCI with DES: meta-analysis supriya kashyap kashyap29 April 2017 4:02 PM ISTAbstractObjective To assess the benefits and risks of short term (<12 months) or extended (>12 months) dual antiplatelet therapy (DAPT) versus...
Anti-aldosterones in STEMI within 24 hour : Reminder Trial supriya kashyap kashyap17 Oct 2017 8:00 PM ISTCertain heart attack patients who have ST-segment elevation myocardial infarction (STEMI) are significantly more likely to survive if they are treated...
Synergy stent with shorter DAPT is superior to a bare-metal stent in elderly patients Anjali Nimesh Nimesh6 Nov 2017 7:15 PM ISTElderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual...
Six months dual antiplatelet therapy as effective as 12 months of DAPT in STEMI Anjali Nimesh Nimesh6 Nov 2017 8:30 PM ISTThe first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ST-elevation myocardial infarction (STEMI) found...
Use of Antiplatelet & Anticoagulation in PCI & AF - Dr Jamshed J Dalal Medical Dialogues Bureau28 Feb 2018 3:30 PM ISTPatients with atrial fibrillation (AF) on novel oral anticoagulation (NOAC) agents who develop an acute coronary syndrome (ACS) or a patient with...
Bioresorbable Stents for Peripheral Vessels - Dr NN Khanna Anjali Nimesh Nimesh28 Feb 2018 3:27 PM ISTPeripheral artery disease is a common manifestation of atherosclerosis, in which the majority of the arterial lesions are located in the...
ESC / EACTS Focused Update on Dual Antiplatelet Therapy in CAD Dr. Kamal Kant Kohli Kohli11 March 2018 7:02 PM ISTThe first ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease has been developed by the Task Force for dual antiplatelet...
Aspirin+ticagrelor improves outcomes after elective CABG Medha Baranwal Baranwal26 April 2018 8:30 PM ISTAdministration of dual antiplatelet therapy (DAPT) comprising of aspirin plus ticagrelor, for one year after coronary artery bypass grafting (CABG)...
Compared to H2RAs,PPIs provide superior gastroprotection in patients on DAPT Vinay Singh singh8 July 2018 8:28 PM ISTProton pump inhibitors(PPIs) are superior to histamine 2 receptors(H2RAs) in terms of gastroprotection reducing the risk of GI complications in...
Dual antiplatelet therapy only up to 3 weeks in minor stroke: Expert Panel Dr. Kamal Kant Kohli Kohli23 Dec 2018 7:28 PM ISTAccording to a new BMJ Rapid Recommendations article, short-term dual antiplatelet therapy up to 3 weeks may be beneficial for patients in minor...
